XENTROVIA Trademark

Trademark Overview


On Friday, February 10, 2017, a trademark application was filed for XENTROVIA with the United States Patent and Trademark Office. The USPTO has given the XENTROVIA trademark a serial number of 87331235. The federal status of this trademark filing is REGISTERED as of Tuesday, April 10, 2018. This trademark is owned by ViiV Healthcare UK (No.4) Limited. The XENTROVIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
xentrovia

General Information


Serial Number87331235
Word MarkXENTROVIA
Filing DateFriday, February 10, 2017
Status700 - REGISTERED
Status DateTuesday, April 10, 2018
Registration Number5441319
Registration DateTuesday, April 10, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "XENTROVIA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameViiV Healthcare UK (No.4) Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameViiV Healthcare UK (No.4) Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameViiV Healthcare UK (No.4) Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, April 10, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 10, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, January 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 6, 2017ASSIGNED TO LIE
Tuesday, November 28, 2017NOTICE OF REVIVAL - E-MAILED
Monday, November 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 27, 2017PETITION TO REVIVE-GRANTED
Monday, November 27, 2017TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 9, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2017NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2017NON-FINAL ACTION WRITTEN
Monday, May 8, 2017ASSIGNED TO EXAMINER
Wednesday, February 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 14, 2017NEW APPLICATION ENTERED